CN Stock MarketDetailed Quotes

688073 Bide Pharmatech

Watchlist
  • 41.69
  • +1.12+2.76%
Market Closed Apr 24 15:00 CST
3.79BMarket Cap31.04P/E (TTM)

About Bide Pharmatech Company

The company was founded in 2007 and is headquartered in Chuangzhihui, Anbo Road, Yangpu District, Shanghai. Since the establishment of the company, it has always adhered to the corporate creed of reputation first and quality first. The products have been widely used in R&D and production fields in life science, organic chemistry, materials science, analytical chemistry and other disciplines, and the sales range is all over the world. Currently, the company has established partnerships with many top pharmaceutical research and development units at home and abroad. The company focuses on the front end of the new drug research and development industry chain. Relying on core businesses such as R&D, design, production and sales of pharmaceutical molecular blocks, the company can provide drug molecular blocks and scientific reagents with novel structures and diverse functions for new drug research and development institutions. The company's main products are pharmaceutical molecular blocks and scientific reagents. Corporate honors: Shanghai “Specialized, Special and New” Small and Medium Enterprises in 2020, National Specialized, Special and New “Little Giant” Enterprises in 2021, etc. “Little Giant of Science and Technology in Shanghai” in 2021, “Shanghai Enterprise Technology Center” in 2023, etc.

Company Profile

Short Name-A毕得医药科技股份
Company NameBide Pharmatech Co., Ltd.
Listing DateOct 11, 2022
Issue Price88.00
Shares Offered16.23M share(s)
FoundedApr 27, 2007
Chairmanlan dai
Legal Representativelan dai
General Managerlan dai
Secretarylandai dai
Employees738
ProvinceShang Hai Shi
Phone021-61601560
Office Address6th Floor, Building 3, No. 999, Xiangyin Road, Yangpu District, Shanghai
Zip Code200433
Registered AddressRoom 101, Block A, Building 11, No. 128, Xiangyin Road, Yangpu District, Shanghai
Fax021-61629029
Emailir@bidepharmatech.com
Business License91310110660715642B
BusinessThe company is a high-tech enterprise focusing on the front end of the new drug research and development industry chain. Relying on core businesses such as R&D, design, production and sales of pharmaceutical molecular blocks, it can provide drug molecular blocks and scientific reagents with novel structures and diverse functions for new drug research and development institutions.

Company Executives

  • Name
  • Position
  • Salary
  • lan dai
  • Directors
  • 2.51M
  • zhichang liu
  • Independent Directors
  • 90.00K
  • jian li
  • Independent Directors, Nomination Committee Members
  • 52.50K
  • yongping tao
  • Independent Directors
  • 90.00K
  • xiaohu yu
  • Securities Affairs Representative
  • --
  • jiangbo wan
  • Auditors
  • 815.80K
  • ronghao li
  • Auditors, Core Technical Personnel
  • 556.80K
  • yun zhao
  • Assistant to the General Manager
  • 1.64M
  • kun wang
  • Chief Financial Officer
  • --
  • dieqing lv
  • Core Technical Personnel
  • 492.60K
  • mingkang zhou
  • Core Technical Personnel
  • --
  • ye tang
  • Core Technical Personnel
  • --
  • ruihao zhang
  • Core Technical Personnel
  • --
  • qinghong cha
  • Core Technical Personnel
  • --
  • taoran mi
  • Core Technical Personnel
  • --
  • xinhan chen
  • Core Technical Personnel
  • --
  • chen ma
  • Core Technical Personnel
  • --